Specific High Performance Liquid Chromatographic Determination of Quinidine in Serum, Blood, and Urine
- 1 March 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 9 (1) , 104-112
- https://doi.org/10.1097/00007691-198703000-00018
Abstract
A reversed-phase high performance liquid chromatographic method for determination of quinidine in serum, blood, and urine has been developed. An alkylnitrile column is used with a mobile phase of acetonitrile in an acetate buffer. The method was rigorously tested and shown to be specific for quinidine using the following methods: (a) comparison of capacity factors among methanolic reference standards of quinidine, known metabolites, and 36 other drugs; (b) comparison of the quinidine capacity factor with the capacity factors from components in patient sera and urines, from which quinidine was selectively removed by thin-layer chromatography; and, (c) correlation of quinidine concentrations in patient sera using ultraviolet absorbance versus fluorescence detection. Application of the method to a single-dose pharmacokinetic study, including serum protein binding and blood/serum concentration ratio measurements, demonstrates excellent sensitivity of the method.This publication has 4 references indexed in Scilit:
- Factors Affecting Quinidine Protein Binding in HumansJournal of Pharmaceutical Sciences, 1984
- Influence of volume shifts on drug binding during equilibrium dialysis: Correction and attenuationJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Rapid High-pressure Liquid Chromatographic Determination of Quinidine and Dihydroquinidine in Plasma SamplesJournal of Pharmaceutical Sciences, 1978
- Specific serum quinidine assay by high-performance liquid chromatography.Clinical Chemistry, 1977